SCHEMBL4015068

SCHEMBL4015068

Cc1cc(C)cc(/C=C/C(=O)NCCc2c(C)[nH]c3c(F)ccc(C)c23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 3/20 0.38
HDAC4 P56524 3/20 0.38
MEF2D Q14814 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 2/20 0.36
ALOX5 P09917 1/20 0.36
MMP1 P03956 1/20 0.36
POLB P06746 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
RECQL P46063 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
HDAC3 O15379 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019849 0.92 MEN1 (0.44) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4016848 0.92 MEN1 (0.44) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4018968 0.91 MEN1 (0.44) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4017819 0.91 MEN1 (0.47) MEN1KMT2AMAPTHDAC4LMNA
SCHEMBL4754752 0.90 MEN1 (0.43) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4669576 0.90 MEN1 (0.43) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4015839 0.90 MEN1 (0.44) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL13982589 0.89 MEN1 (0.43) MEN1KMT2AMAPTHDAC4CYP1A2
SCHEMBL4017825 0.89 MMP1 (0.50) MEN1KMT2AMAPTHDAC4MEF2D
SCHEMBL4017820 0.88 MAPT (0.50) MEN1KMT2AMAPTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2014287-A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor Bayer Schering Pharma Aktiengesellschaft (DE) 2009-01-14 EP claimed
EP-2014287-A1 Use of cinnamic acid derivatives as modulators of an EP2 receptor Bayer Schering Pharma Aktiengesellschaft (DE) 2009-01-14 EP disclosed